RS4507958 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (16)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Metabolite levels (10-undecenoate (11:1n1)) | T | OR: 0.48 | 8E-106 | PubMed |
| Serum metabolite levels | A | OR: 0.5 | 6E-61 | PubMed |
| Eicosanoid 17-HETE, Eicosanoid 18(+/-)-HETE, Eicosanoid 20-HETE levels | — | OR: 0.31 | 3E-52 | PubMed |
| Metabolite peak levels (QI2190) | T | OR: 0.42 | 2E-40 | PubMed |
| X-14939 levels | T | OR: 0.32 | 4E-36 | PubMed |
| Metabolite peak levels (QI2188) | T | OR: 0.35 | 3E-29 | PubMed |
| X-18922 levels | A | OR: 0.17 | 2E-28 | PubMed |
| Metabolite peak levels (QI5541) | T | OR: 0.31 | 1E-23 | PubMed |
| Metabolite peak levels (QI10705) | T | OR: 0.29 | 7E-21 | PubMed |
| diHOME levels (313.2379_0.355) | — | OR: 0.14 | 2E-15 | PubMed |
| Urine glutamine conjugate of C10H16O2 (2)* levels in chronic kidney disease | T | OR: 0.28 | 6E-15 | PubMed |
| Total cholesterol levels | A | β: 0.015 | 2E-14 | PubMed |
| Serum metabolite concentrations in chronic kidney disease | — | OR: 0.42 | 4E-14 | PubMed |
| Metabolite peak levels (QI10834) | T | OR: 0.23 | 8E-14 | PubMed |
| Metabolite peak levels (QI5469) | T | OR: 0.22 | 1E-12 | PubMed |
| Low-density lipoprotein levels | A | β: 0.013 | 2E-10 | PubMed |